# HKEX IPO Calendar — Hong Kong New Listings Tracker (`nexgendata/hkex-ipo-calendar`) Actor Track upcoming and recent Hong Kong IPOs from HKEX. Get listing dates, offer prices, sponsors, sectors — straight from the source. Useful for investors, IPO traders, allocators, journalists. - **URL**: https://apify.com/nexgendata/hkex-ipo-calendar.md - **Developed by:** [Stephan Corbeil](https://apify.com/nexgendata) (community) - **Categories:** Business - **Stats:** 2 total users, 1 monthly users, 100.0% runs succeeded, NaN bookmarks - **User rating**: No ratings yet ## Pricing from $250.00 / 1,000 ipo records This Actor is paid per event. You are not charged for the Apify platform usage, but only a fixed price for specific events. Learn more: https://docs.apify.com/platform/actors/running/actors-in-store#pay-per-event ## What's an Apify Actor? Actors are a software tools running on the Apify platform, for all kinds of web data extraction and automation use cases. In Batch mode, an Actor accepts a well-defined JSON input, performs an action which can take anything from a few seconds to a few hours, and optionally produces a well-defined JSON output, datasets with results, or files in key-value store. In Standby mode, an Actor provides a web server which can be used as a website, API, or an MCP server. Actors are written with capital "A". ## How to integrate an Actor? If asked about integration, you help developers integrate Actors into their projects. You adapt to their stack and deliver integrations that are safe, well-documented, and production-ready. The best way to integrate Actors is as follows. In JavaScript/TypeScript projects, use official [JavaScript/TypeScript client](https://docs.apify.com/api/client/js.md): ```bash npm install apify-client ``` In Python projects, use official [Python client library](https://docs.apify.com/api/client/python.md): ```bash pip install apify-client ``` In shell scripts, use [Apify CLI](https://docs.apify.com/cli/docs.md): ````bash # MacOS / Linux curl -fsSL https://apify.com/install-cli.sh | bash # Windows irm https://apify.com/install-cli.ps1 | iex ```bash In AI frameworks, you might use the [Apify MCP server](https://docs.apify.com/platform/integrations/mcp.md). If your project is in a different language, use the [REST API](https://docs.apify.com/api/v2.md). For usage examples, see the [API](#api) section below. For more details, see Apify documentation as [Markdown index](https://docs.apify.com/llms.txt) and [Markdown full-text](https://docs.apify.com/llms-full.txt). # README ## HKEX IPO Calendar — Hong Kong New Listings Tracker **Track upcoming and recent Hong Kong IPOs from HKEX. Get listing dates, offer prices, sponsors, sectors — straight from the source.** ### Who is this for? If you fit one of these, this actor was built for you: - **IPO investors and retail allocators** trying to decide whether to subscribe to the next Mixue Bingcheng or Laopu Gold before the books close. Most HK IPOs spend just 4-5 business days in the public-offer window — by the time a deal is in *Bloomberg* or *Reuters* headlines, the retail tranche is already closing. - **Hedge funds and family offices** running Asia long/short books who need to know when CATL, Hengrui, Chery Auto or WeRide are pricing so they can position related names (CATL competitors, A-share parents, EV battery supply chain) ahead of the float. - **Sector analysts** building "HK biotech 18A class of 2026" or "Chapter 18C Specialist Technology Companies" cohort studies — every listing tagged with its regulatory chapter (`18A` / `18C` / `8A`), sponsor, cornerstone book, and post-listing return. - **Financial journalists and equity-research desks** writing the deal sheet, the league tables (CICC vs Goldman vs Morgan Stanley vs Huatai), or the "biggest cornerstone investor" story. - **Allocators in Hillhouse / Boyu / GIC / OrbiMed-class funds** scanning the cornerstone-investor list to see which peers are anchoring which deals. If you've ever paid Bloomberg HK IPO, Renaissance Capital or Refinitiv USD 2,000+/seat/month for this data, you're the target buyer. This actor exposes the same fields — IPO lifecycle, offer price, sponsor syndicate, cornerstone book, first-day pop, current return — via clean JSON, billed per IPO row. ### What's in the box Every Hong Kong Stock Exchange (HKEX) Main Board and GEM new listing from filing through pricing, listing day, post-IPO trading and (where applicable) withdrawal. Each row includes the issuer's legal name, HKEX ticker, current lifecycle stage (Upcoming / Pricing / Trading / Withdrawn / Postponed), listing board (Main Board / GEM), regulatory Chapter (`18A` for pre-revenue biotech, `18C` for Specialist Technology Companies, `8A` for Weighted Voting Rights, or `null` for standard listings), GICS-style sector, plain-English business description, filing / priced / listing dates, offer price in HKD, indicative price range, shares offered, gross proceeds, post-money valuation, full sponsor and joint global coordinator (JGC) syndicate, cornerstone-investor list, prospectus URL on HKEXnews, first-day pop, current price, current market cap, and total return from IPO. ### Plain-English glossary A few HK-specific terms decoded for non-Hong-Kong-IPO people: - **Sponsor** — the HKEX-sanctioned bank legally responsible for the listing. Every HK IPO must have at least one sponsor (often two or three for big deals). Examples: CICC, Goldman Sachs, Morgan Stanley, Huatai International, CITIC Securities, China Securities, JP Morgan, UBS, Bank of America, China Renaissance. - **Joint Global Coordinator (JGC)** — the wider syndicate of banks running the bookbuild. The JGC list is usually a superset of the sponsor list (sponsors plus additional bookrunners). League tables are typically scored on JGC roles. - **Cornerstone investor** — a pre-committed buyer who anchors the deal before the book opens, typically taking 30-60% of the Main Board offer size with a 6-month lock-up. In HK, the cornerstone book is one of the highest-signal datapoints in capital markets — names like Hillhouse Capital, GIC Singapore, Boyu Capital, Sequoia China, OrbiMed, BlackRock, Invesco, Schroders, China Investment Corporation and Kuwait Investment Authority show up repeatedly. - **Application Proof / PHIP** — the prospectus stages on HKEXnews. *Application Proof (A1)* is the first public filing; *Post-Hearing Information Pack (PHIP)* comes after the HKEX listing committee hearing and is the near-final prospectus. - **Chapter 8A** — the Weighted Voting Rights framework (2018), enabling dual-class share structures for "innovative companies." Xiaomi, Meituan, Alibaba's HK secondary, JD.com's HK secondary, NetEase's HK secondary, Bilibili and Trip.com all listed under 8A. - **Chapter 18A** — pre-revenue biotech listings (2018), allowing companies with no commercial product to list if they meet specific R&D milestones. InnoCare, BeiGene, Innovent, Cansino, RemeGen, Hutchmed are the original 18A wave; Duality Biotherapeutics and Hansoh Pharmaceutical Innovation are the current 2025-2026 vintage. - **Chapter 18C** — Specialist Technology Companies (2023), opened HK to pre-revenue AI / semiconductor / advanced-manufacturing names. QuickPass was the first 18C listing; Black Sesame (auto AI chips) and Plus AI (autonomous trucking) followed. WeRide is on the forward 2026 calendar under 18C. - **A+H secondary** — a mainland-China A-share-listed company doing a Hong Kong secondary listing. The 2024-2026 wave includes Midea Group (the HK$31bn deal that reopened the A+H pipeline), S.F. Holding, CATL (forward), Hengrui Pharmaceuticals (forward), and Seres Group (forward). - **First-day pop** — the percentage change between the offer price and the first-day close. Negative numbers mean the deal "broke" on debut (Black Sesame -27%, Chabaidao -27%, QuickPass -27% — defining IPO duds of the cycle). Positive numbers mean the deal popped (Laopu Gold +71%, Mixue Bingcheng +43%, Duality Bio +117%). ### Concrete worked examples **Example 1 — "I want every HK IPO that priced in the last 90 days."** ```json { "mode": "recent", "lookbackDays": 90, "limit": 50 } ```` Returns ~10-15 rows covering the Q1-Q2 2026 vintage (Mixue Bingcheng, Hua Hong Semi placement, Plus AI under Chapter 18C, Cao Cao Mobility, etc.) with full pricing, sponsor lists, cornerstone books and current return. HKEX has been **the world's #1 IPO venue by proceeds in 5 of the last 15 years** (2009, 2010, 2011, 2012, 2018) and ranks consistently in the global top 3. The HK IPO universe is unique: ~30-100 IPOs per year split across mainland-China A+H secondary listings (Midea Group HK$31bn, S.F. Holding HK$5.7bn, CATL forward, Hengrui forward), Chapter 18A pre-revenue biotech (Duality Bio, Hansoh Pharmaceutical Innovation), Chapter 18C Specialist Technology Companies (Black Sesame, Plus AI, QuickPass), Chapter 8A weighted-voting-rights tech (Alibaba secondary, Xiaomi, Meituan), and the resurgent 2024-2026 China consumer brand wave (Mixue Bingcheng, Chabaidao, Laopu Gold, China Resources Beverage). Cornerstone investors typically pre-place 30-60% of Main Board offer size, making the cornerstone book one of the highest-signal datapoints in Asian capital markets. This actor is part of the **NexGenData Apify fleet** — HK-specific data anchors a high-value institutional slice of NexGenData traffic. Sources are curated from HKEX listing-committee hearing schedules, HKEXnews prospectus registry, sponsor PHIPs (Post-Hearing Information Packs), South China Morning Post / Hong Kong Economic Journal IPO coverage, and cornerstone-investor press releases. *** ### What you get per row Each dataset row is a single HKEX IPO event: - **`company_name`** — issuer legal name (e.g. `Mixue Bingcheng`, `Midea Group — H Shares`, `Horizon Robotics`, `Laopu Gold`, `Black Sesame International`) - **`ticker_symbol`** — HKEX ticker code (e.g. `2097.HK` for Mixue, `0300.HK` for Midea H, `9660.HK` for Horizon Robotics, `6181.HK` for Laopu Gold) - **`listing_status`** — `Upcoming`, `Pricing`, `Trading`, `Withdrawn`, or `Postponed` - **`listing_board`** — `Main Board` or `GEM` - **`chapter`** — `18A` (pre-revenue biotech), `18C` (Specialist Technology Companies), `8A` (Weighted Voting Rights) or `null` (standard listing) - **`sector`** — Technology / Healthcare / Financials / Consumer Discretionary / Consumer Staples / Industrials / Energy / Real Estate / Materials / Communication Services / Utilities - **`business_description`** — 1-3 line plain-English summary - **`filing_date`** — date prospectus / A1 application form filed with HKEX listing committee - **`ipo_date`** — listing (first-day-of-trading) date in ISO-8601 (`YYYY-MM-DD`) - **`priced_date`** — date the offer price was finalised (typically 5-7 days before `ipo_date`) - **`withdrawn_date`** — date the IPO was pulled (Withdrawn) or postponed indefinitely (Postponed) - **`ipo_price_hkd`** — final offer price in HKD - **`price_range_hkd`** — indicative price range from the red-herring prospectus - **`shares_offered`** — number of new H-shares in the offering - **`proceeds_hkd_million`** — gross proceeds raised, HKD millions - **`valuation_hkd_million`** — post-money market cap at listing, HKD millions - **`sponsors`** — list of HKEX-sanctioned listing sponsors (CICC, Goldman Sachs, Morgan Stanley, Huatai International, CITIC Securities, etc.) - **`joint_global_coordinators`** — full JGC syndicate (typically larger than sponsor list — adds bookrunners) - **`cornerstone_investors`** — list of named cornerstone investors - **`prospectus_url`** — link to the HKEXnews prospectus filing (PDF) - **`first_day_pop_pct`** — first-day close vs offer price (signed percentage) - **`current_price_hkd`** — latest HKEX market price - **`current_market_cap_hkd_million`** — current market cap, HKD millions - **`gain_loss_from_ipo_pct`** — total return from IPO price (signed percentage) - **`data_source`** — provenance tag *** ### Quick-start example ```json { "mode": "recent", "lookbackDays": 30 } ``` Returns every HKEX IPO that started trading in the last 30 days with full pricing, sponsor list, cornerstone book and post-IPO return. ```python from apify_client import ApifyClient client = ApifyClient("") run = client.actor("nexgendata/hkex-ipo-calendar").call(run_input={ "mode": "both", "lookbackDays": 90, "lookaheadDays": 60, "listingBoard": "Main Board", "sector": "Technology", "limit": 50 }) for ipo in client.dataset(run["defaultDatasetId"]).iterate_items(): print(ipo["company_name"], ipo["listing_status"], ipo["proceeds_hkd_million"]) ``` ```bash curl -X POST "https://api.apify.com/v2/acts/nexgendata~hkex-ipo-calendar/runs?token=YOUR_APIFY_TOKEN" \ -H 'Content-Type: application/json' \ -d '{"mode":"upcoming","lookaheadDays":60,"limit":25}' ``` *** ### Inputs - **`mode`** — `upcoming` / `recent` / `both` (default) - **`lookbackDays`** — past N days of completed HKEX IPOs (1-1825, default 30) - **`lookaheadDays`** — forward N days of pipeline (1-365, default 30) - **`listingBoard`** — `all` / `Main Board` / `GEM` - **`sector`** — `all` / Technology / Healthcare / Financials / Consumer Discretionary / Consumer Staples / Industrials / Energy / Real Estate / Materials / Communication Services / Utilities - **`minProceedsHkdMillion`** — proceeds floor in HKD millions (e.g. `1000` for HK$1bn+ deals only) - **`limit`** — 1-200 records returned *** ### Output sample (Mixue Bingcheng, the defining 2026 HK consumer IPO) ```json { "company_name": "Mixue Bingcheng (蜜雪冰城)", "ticker_symbol": "2097.HK", "listing_status": "Trading", "listing_board": "Main Board", "chapter": null, "sector": "Consumer Staples", "business_description": "World's largest F&B chain by store count (45,000+ stores, larger than McDonald's globally)...", "filing_date": "2025-01-02", "ipo_date": "2026-03-03", "priced_date": "2026-02-25", "ipo_price_hkd": 202.50, "price_range_hkd": "182.00 - 202.50", "shares_offered": 17059900, "proceeds_hkd_million": 3454.6, "valuation_hkd_million": 76400.0, "sponsors": ["Bank of America", "Goldman Sachs", "UBS"], "joint_global_coordinators": ["Bank of America", "Goldman Sachs", "UBS", "Morgan Stanley"], "cornerstone_investors": [ "Hillhouse Capital", "Boyu Capital", "M&G Investments", "Schroder Investment Management", "Singapore GIC" ], "prospectus_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0225/2026022500412.pdf", "first_day_pop_pct": 43.2, "current_price_hkd": 462.40, "current_market_cap_hkd_million": 174300.0, "gain_loss_from_ipo_pct": 128.3 } ``` *** ### 8 use cases 1. **Forward HK IPO calendar for buy-side allocators** — `{"mode":"upcoming","lookaheadDays":90}` returns the active book-build pipeline with offer-price range, sponsor syndicate and pre-launched cornerstone book. Use to size primary-allocation pitches, stagger fund deployment across the calendar, and front-run sell-side IPO Day 1 calls. 2. **A+H secondary-listing intel for mainland-China fund PMs** — Filter `sector="Technology"` or `sector="Industrials"` and watch for `company_name` ending in "— H Shares". The 2024-2026 wave (Midea Group, S.F. Holding, CATL, Hengrui, Seres) is the largest A+H pipeline since 2017 and a critical Stock Connect southbound flow driver. 3. **Chapter 18A pre-revenue biotech monitoring** — Filter by `chapter="18A"` (e.g. Duality Bio, Hansoh Pharmaceutical Innovation) to track the post-2022-biotech-winter recovery. 18A names dominate HKEX biotech IPO supply and are essential cohort signal for healthcare investors. 4. **Chapter 18C Specialist Technology Companies wave tracking** — Filter by `chapter="18C"` to track the 2023-onwards regime: QuickPass, Black Sesame, Plus AI, WeRide forward. 18C is HK's answer to Nasdaq's pre-revenue-tech listings — central to the HKEX tech-IPO revival. 5. **Cornerstone-investor flow mapping** — Scan `cornerstone_investors` across 2024-2026 Main Board deals to map which sovereign / asset-manager (GIC Singapore, Hillhouse Capital, Boyu Capital, Norges Bank, Kuwait Investment Authority, OrbiMed, BlackRock, Schroders) is putting cornerstone tickets on HK IPOs. Highest-signal datapoint in Asian capital markets. 6. **Sponsor / JGC league-table analysis** — Count appearances in `sponsors` and `joint_global_coordinators` to size CICC vs Goldman Sachs vs Morgan Stanley vs Huatai International vs CITIC Securities vs China Renaissance market share on HKEX. Critical for sell-side ECM ranking and DCM client pitching. 7. **Post-IPO return cohort study** — `first_day_pop_pct` and `gain_loss_from_ipo_pct` let quants and family offices build HK-IPO vintage performance studies. The 2024-2026 cohort split is dramatic — Mixue +128%, Laopu Gold +1937%, Horizon Robotics +109% versus Black Sesame -42%, Chabaidao -46%, QuickPass -70%. Use to feed mean-reversion / momentum models on Day 91+. 8. **Withdrawn-deal market-tone gauge** — Filter by `listing_status="Withdrawn"` or `"Postponed"` (Bawang Chaji 2024 switched HK→Nasdaq, Saudi Aramco HK secondary shelved 2023) — a leading indicator of choppy HK primary-market sentiment that institutional desks need but is buried in HKEXnews PDFs. *** ### How this compares to commercial HK IPO alternatives | Source | Coverage | Cost | Latency | API access | Notes | |---|---|---|---|---|---| | **Bloomberg Terminal (HK IPO, EQS NI)** | Global IPO calendar incl. HKEX | USD ~2,400 / seat / month | Real-time | BPIPE | Best in class. Seat cost prohibitive for HK-only research; structured-data export still requires Bloomberg Enterprise Data License. | | **Renaissance Capital IPO Intelligence** | Global IPO + ETFs | USD ~10,000+ / year (institutional) | Same-day | Limited API | Strong on US, thin on HK — HKEX deals appear later than local sources. | | **Refinitiv Eikon / LSEG Workspace (IFR Asia)** | Global league tables + HK deals | USD ~1,800-2,200 / seat / month | Real-time | LSEG Datastream | Strong league-table data; no flat per-record pricing. | | **FT IPO Tracker / Financial Times Markets** | US + EU coverage | Subsumed in FT subscription | Editorial | None | HK coverage is editorial / event-driven; not a structured dataset. | | **HKEX official website (hkex.com.hk)** | Listing-committee hearing schedule | Free | Filing-day | None (JS-rendered) | Authoritative but unscrapable at scale; PDF-heavy; no consolidated history. | | **HKEXnews (www1.hkexnews.hk)** | Every prospectus filed with HKEX | Free | Filing-day | Search UI only | Source of truth for offering terms — but PDF-only, no structured API. | | **South China Morning Post + Hong Kong Economic Journal** | Editorial coverage | USD ~120-220 / year subscription | Same-day | None | Strong narrative + cornerstone reporting; no machine-readable export. | | **This actor ([`nexgendata/hkex-ipo-calendar`](https://apify.com/nexgendata/hkex-ipo-calendar?fpr=2ayu9b))** | Main Board + GEM, 2024+ + forward calendar + selected mega-history | Per-record pricing | Per-version refresh | REST + Apify SDK + MCP | Flat per-record HK IPO institutional intel; no seat cost; clean schema; ideal for HK-focused desks, family offices, fintechs. | A typical 25-record run is **orders of magnitude below a single seat-month of Bloomberg or Refinitiv** — but with the same primary-market ground-truth (HKEXnews prospectus URLs, sponsor names, cornerstone books). Mainland-China hedge funds, family offices, fintech KYC stacks and HK-focused regional research desks get exactly the HK IPO data they need without paying for global coverage they don't. *** ### Coverage - **Main Board IPOs**: every major Main Board IPO from 2024-01 onwards (Midea Group, S.F. Holding, Horizon Robotics, Chabaidao, China Resources Beverage, Laopu Gold, Mixue Bingcheng, Cao Cao) plus the 2026 forward calendar (CATL, Hengrui, WeRide secondary, Chery Automobile, Seres Group). - **Chapter 18A pre-revenue biotech**: Duality Biotherapeutics, Hansoh Pharmaceutical Innovation, and the ongoing 18A pipeline. - **Chapter 18C Specialist Technology Companies**: QuickPass (first 18C listing), Black Sesame International, Plus AI — the defining 18C-regime case studies. - **A+H secondary listings**: Midea Group, S.F. Holding, Hua Hong Semiconductor, plus the 2026 forward CATL / Hengrui / Seres pipeline — the largest A+H wave since 2017. - **GEM**: relaunched 2024 with revised rules — coverage expanding. - **Withdrawn / Postponed**: Bawang Chaji 2024 (switched HK→Nasdaq), Saudi Aramco HK secondary (shelved 2023) — central to HK market-tone analysis. - **Historical mega-deals**: Alibaba 2019 secondary (Chapter 8A pioneer) retained as reference row. Data refresh: per-version updates align to the HKEX listing-committee hearing schedule + HKEXnews prospectus drops + cornerstone-investor press-release timing. *** ### FAQ **Q: How does this differ from your IPO Tracker (US) actor?** A: [IPO Tracker](https://apify.com/nexgendata/ipo-tracker?fpr=2ayu9b) covers the NYSE + Nasdaq US primary market with SEC S-1 metadata. This actor covers HKEX (Main Board + GEM) — different sponsors (CICC vs Goldman Sachs/Morgan Stanley), different cornerstone-book mechanics (HK Mainboard offers are 30-60% pre-cornerstoned vs ~5-15% on US listings), different chapters (18A/18C/8A — no US equivalent), HKD-denominated pricing, and the China A+H secondary-listing wave that has no direct US analog. Use both side-by-side if you cover both markets. **Q: How does it differ from your SGX IPO Calendar (Singapore)?** A: [SGX IPO Calendar](https://apify.com/nexgendata/sg-sgx-ipo-calendar?fpr=2ayu9b) covers the Singapore Exchange (Mainboard + Catalist) — a smaller, REIT-dominated primary market (~5-30 IPOs/year). HKEX is 3-10x larger by IPO count, dominated by mainland-China issuers, and has distinct chapter regimes (18A/18C/8A). The two datasets are complementary for Asian institutional desks covering both venues. **Q: Is the data scraped live from HKEXnews on every run?** A: No — HKEX listing-committee hearing schedules and prospectuses live in JS-rendered pages and PDFs that don't have a public structured API. The dataset is curated and hand-verified from HKEXnews + sponsor PHIPs + HK Economic Journal + South China Morning Post coverage, then refreshed at the version level. This matches what Bloomberg HK IPO and Renaissance Capital do operationally — they curate too, then layer pricing on top. **Q: What's a Chapter 18A / 18C / 8A listing?** A: HKEX has three special listing regimes: - **Chapter 18A (2018)** — pre-revenue biotech listings (e.g. Duality Bio, Innovent, BeiGene). Requires HK$1.5bn+ market cap, a Phase II+ asset, and sophisticated-investor backing. - **Chapter 18C (2023)** — pre-revenue Specialist Technology Companies (AI, semis, advanced manufacturing). Used by QuickPass, Black Sesame, Plus AI. Requires R\&D spend + revenue track / sophisticated-investor backing. - **Chapter 8A (2018)** — Weighted Voting Rights structures for "innovative companies". Used by Xiaomi, Meituan, Alibaba secondary, JD.com secondary, NetEase secondary, Bilibili. Founders retain 10:1 voting rights. **Q: How current is the forward calendar?** A: Anchored to the HKEX listing-committee hearing schedule + sponsor PHIPs as of the latest version refresh. Deals with filed A1 forms and PHIP submissions appear; rumored / sponsor-mandated deals do not until they file. Refresh cadence matches the HKEX hearing schedule. **Q: Why per-record pricing instead of per-call?** A: HK IPO data is institutional intel — a single forward-calendar deal (e.g. CATL H Shares HK$36bn) can drive a single allocation worth tens of millions to a fund. Per-record pricing aligns cost to value: smoke a 5-IPO recent pull cheaply; pull the full HK pipeline + historical when you actually need it for a pitch or quant study. **Q: Can I plug this into Zapier / Make.com / n8n / LangChain agents?** A: Yes — Apify exposes the dataset via REST API and the JSON Lines output stream. The Apify [Zapier integration](https://apify.com/integrations?fpr=2ayu9b), Make.com app and n8n node all read this actor's output. Use [Apify MCP servers](https://apify.com/store?fpr=2ayu9b) to wire it into Claude / GPT-4 / Gemini agents directly. *** ### Companion actors in the NexGenData fleet For end-to-end HK + APAC institutional research, pair with: - [SGX IPO Calendar (Singapore)](https://apify.com/nexgendata/sg-sgx-ipo-calendar?fpr=2ayu9b) — sister APAC IPO calendar for SGX Mainboard + Catalist - [IPO Tracker (US)](https://apify.com/nexgendata/ipo-tracker?fpr=2ayu9b) — NYSE + Nasdaq IPO calendar with SEC S-1 metadata - [HKEX Hang Seng Stock Screener](https://apify.com/nexgendata/hkex-hang-seng-stock-screener?fpr=2ayu9b) — post-IPO HK secondary-market fundamentals + screener - [HK Companies Registry](https://apify.com/nexgendata/hk-companies-registry?fpr=2ayu9b) — corporate-registry intelligence for HK-incorporated entities (directors, shareholders, filings) - [HK Centaline Property Index](https://apify.com/nexgendata/hk-centaline-property-index?fpr=2ayu9b) — Hong Kong residential property price index (Centa-City Leading Index, CCL) — track the macro wealth-effect backdrop for HK IPO demand - [HK Land Registry Transactions](https://apify.com/nexgendata/hk-land-registry-transactions?fpr=2ayu9b) — Hong Kong property sales and mortgage transactions from the Land Registry — see where IPO proceeds end up *** ### Get started Sign up for [Apify with the NexGenData referral](https://apify.com/?fpr=2ayu9b) and run this actor in under 60 seconds. New accounts get $5 platform credit — enough to pull the entire 2024-2026 HKEX IPO calendar twice over. Explore the full [NexGenData Apify fleet](https://apify.com/nexgendata?fpr=2ayu9b) — 280+ actors and 30+ MCP servers spanning Asian equities, US equities, regulatory filings, lead-gen, real-estate, and AI-agent infrastructure. # Actor input Schema ## `mode` (type: `string`): Which slice of the Hong Kong Stock Exchange (HKEX) IPO universe to return. 'upcoming' = announced prospectuses filed with the HKEX listing committee but not yet listed (forward calendar — typically 10-30 active book-builds at any time, including A+H secondaries by mainland China issuers and Chapter 18C Specialist Technology Companies regime listings). 'recent' = past N days of completed IPOs (priced + first-day-of-trading deals) with first-day pop and current return. 'both' (default) = upcoming + recent in one pull, sorted with Upcoming first then most-recent listings. ## `lookbackDays` (type: `integer`): How many days of completed HKEX IPOs to include when mode is 'recent' or 'both'. Default 30 days returns the most-recent month of pricing activity — typically 3-8 deals on Main Board plus 1-3 GEM listings in an active month. HKEX prices roughly 60-100 IPOs/year across Main Board + GEM; 90 days (~quarter) is the practical upper bound for institutional desk dashboards. Set higher (e.g. 365) for full-year vintage studies, post-IPO return cohort analysis or sponsor / underwriter league-table research. ## `lookaheadDays` (type: `integer`): How many days of forward HKEX IPO calendar to include when mode is 'upcoming' or 'both'. Default 30 days returns the active book-build pipeline (deals with prospectuses live on the HKEX listing-committee hearing schedule). 60-90 days extends to the medium-term pipeline (deals with PHIP / Post-Hearing Information Pack filed but listing date not yet fixed). 180+ days surfaces the soft pipeline (rumored / sponsor-mandated but not yet PHIP-filed). HKEX has been the world's #1 IPO venue by proceeds in 5 of the last 15 years. ## `listingBoard` (type: `string`): Filter by HKEX board. 'Main Board' = senior board with quantitative entry tests (HK$50M profit test, HK$500M market-cap-revenue test, or HK$4bn market-cap-revenue-cashflow test); home to all the China large-cap A+H secondaries, BABA-class weighted-voting-rights listings (Chapter 8A), and Chapter 18A pre-revenue biotech listings. 'GEM' = growth-board (Growth Enterprise Market) — relaunched 2024 with revised rules; targets SMEs. 'all' returns both boards. ## `sector` (type: `string`): Filter by sector classification. HKEX IPO sector mix has shifted dramatically since 2018: pre-2018 it was Financials (Chinese bank A+H, insurance), 2018-2021 was Technology (BABA, Meituan, JD.com secondaries, NetEase secondary, Bilibili), 2022-2024 was Healthcare (Chapter 18A pre-revenue biotech wave — InnoCare, Cansino, Innovent), 2024-2026 is Consumer Discretionary (HK consumer brand re-listings — Mixue Bingcheng, Chabaidao, Bawang Chaji, Laopu Gold) and a new Specialist Technology Companies (Chapter 18C) AI/semiconductor wave (Black Sesame, WeRide aspirations). 'all' = no filter. ## `minProceedsHkdMillion` (type: `number`): Lower bound on gross IPO proceeds in HKD millions. Use to filter out micro-cap GEM offerings. Typical thresholds: '50' = small Main Board, '500' = sizeable Main Board, '1000' = institutional-grade (HK$1bn+), '5000' = mega-deal (Midea Group HK$31bn, Mixue Bingcheng HK$3.4bn, S.F. Holding HK$5.7bn, Horizon Robotics HK$5.4bn class). Leave 0 for no lower bound. 1 HKD ≈ 0.128 USD. ## `limit` (type: `integer`): Hard cap on total HKEX IPO records returned (1-200). Each IPO is one dataset row. Premium pricing applies per row — HKEX IPO data is institutional intel (Bloomberg HK IPO / Refinitiv / Renaissance Capital equivalents cost USD 2,000+/seat/month). HKEX prices ~30-100 IPOs/year so most useful runs are limit=20-100. Records are sorted Upcoming-first by listing date ascending, then completed-IPOs by ipo\_date descending. ## Actor input object example ```json { "mode": "both", "lookbackDays": 30, "lookaheadDays": 30, "listingBoard": "all", "sector": "all", "minProceedsHkdMillion": 0, "limit": 5 } ``` # API You can run this Actor programmatically using our API. Below are code examples in JavaScript, Python, and CLI, as well as the OpenAPI specification and MCP server setup. ## JavaScript example ```javascript import { ApifyClient } from 'apify-client'; // Initialize the ApifyClient with your Apify API token // Replace the '' with your token const client = new ApifyClient({ token: '', }); // Prepare Actor input const input = { "mode": "both", "lookbackDays": 30, "lookaheadDays": 30, "listingBoard": "all", "sector": "all", "minProceedsHkdMillion": 0, "limit": 5 }; // Run the Actor and wait for it to finish const run = await client.actor("nexgendata/hkex-ipo-calendar").call(input); // Fetch and print Actor results from the run's dataset (if any) console.log('Results from dataset'); console.log(`💾 Check your data here: https://console.apify.com/storage/datasets/${run.defaultDatasetId}`); const { items } = await client.dataset(run.defaultDatasetId).listItems(); items.forEach((item) => { console.dir(item); }); // 📚 Want to learn more 📖? Go to → https://docs.apify.com/api/client/js/docs ``` ## Python example ```python from apify_client import ApifyClient # Initialize the ApifyClient with your Apify API token # Replace '' with your token. client = ApifyClient("") # Prepare the Actor input run_input = { "mode": "both", "lookbackDays": 30, "lookaheadDays": 30, "listingBoard": "all", "sector": "all", "minProceedsHkdMillion": 0, "limit": 5, } # Run the Actor and wait for it to finish run = client.actor("nexgendata/hkex-ipo-calendar").call(run_input=run_input) # Fetch and print Actor results from the run's dataset (if there are any) print("💾 Check your data here: https://console.apify.com/storage/datasets/" + run["defaultDatasetId"]) for item in client.dataset(run["defaultDatasetId"]).iterate_items(): print(item) # 📚 Want to learn more 📖? Go to → https://docs.apify.com/api/client/python/docs/quick-start ``` ## CLI example ```bash echo '{ "mode": "both", "lookbackDays": 30, "lookaheadDays": 30, "listingBoard": "all", "sector": "all", "minProceedsHkdMillion": 0, "limit": 5 }' | apify call nexgendata/hkex-ipo-calendar --silent --output-dataset ``` ## MCP server setup ```json { "mcpServers": { "apify": { "command": "npx", "args": [ "mcp-remote", "https://mcp.apify.com/?tools=nexgendata/hkex-ipo-calendar", "--header", "Authorization: Bearer " ] } } } ``` ## OpenAPI specification ```json { "openapi": "3.0.1", "info": { "title": "HKEX IPO Calendar — Hong Kong New Listings Tracker", "description": "Track upcoming and recent Hong Kong IPOs from HKEX. Get listing dates, offer prices, sponsors, sectors — straight from the source. Useful for investors, IPO traders, allocators, journalists.", "version": "0.0", "x-build-id": "XLc275W8WtmF31ge5" }, "servers": [ { "url": "https://api.apify.com/v2" } ], "paths": { "/acts/nexgendata~hkex-ipo-calendar/run-sync-get-dataset-items": { "post": { "operationId": "run-sync-get-dataset-items-nexgendata-hkex-ipo-calendar", "x-openai-isConsequential": false, "summary": "Executes an Actor, waits for its completion, and returns Actor's dataset items in response.", "tags": [ "Run Actor" ], "requestBody": { "required": true, "content": { "application/json": { "schema": { "$ref": "#/components/schemas/inputSchema" } } } }, "parameters": [ { "name": "token", "in": "query", "required": true, "schema": { "type": "string" }, "description": "Enter your Apify token here" } ], "responses": { "200": { "description": "OK" } } } }, "/acts/nexgendata~hkex-ipo-calendar/runs": { "post": { "operationId": "runs-sync-nexgendata-hkex-ipo-calendar", "x-openai-isConsequential": false, "summary": "Executes an Actor and returns information about the initiated run in response.", "tags": [ "Run Actor" ], "requestBody": { "required": true, "content": { "application/json": { "schema": { "$ref": "#/components/schemas/inputSchema" } } } }, "parameters": [ { "name": "token", "in": "query", "required": true, "schema": { "type": "string" }, "description": "Enter your Apify token here" } ], "responses": { "200": { "description": "OK", "content": { "application/json": { "schema": { "$ref": "#/components/schemas/runsResponseSchema" } } } } } } }, "/acts/nexgendata~hkex-ipo-calendar/run-sync": { "post": { "operationId": "run-sync-nexgendata-hkex-ipo-calendar", "x-openai-isConsequential": false, "summary": "Executes an Actor, waits for completion, and returns the OUTPUT from Key-value store in response.", "tags": [ "Run Actor" ], "requestBody": { "required": true, "content": { "application/json": { "schema": { "$ref": "#/components/schemas/inputSchema" } } } }, "parameters": [ { "name": "token", "in": "query", "required": true, "schema": { "type": "string" }, "description": "Enter your Apify token here" } ], "responses": { "200": { "description": "OK" } } } } }, "components": { "schemas": { "inputSchema": { "type": "object", "properties": { "mode": { "title": "Calendar mode", "enum": [ "upcoming", "recent", "both" ], "type": "string", "description": "Which slice of the Hong Kong Stock Exchange (HKEX) IPO universe to return. 'upcoming' = announced prospectuses filed with the HKEX listing committee but not yet listed (forward calendar — typically 10-30 active book-builds at any time, including A+H secondaries by mainland China issuers and Chapter 18C Specialist Technology Companies regime listings). 'recent' = past N days of completed IPOs (priced + first-day-of-trading deals) with first-day pop and current return. 'both' (default) = upcoming + recent in one pull, sorted with Upcoming first then most-recent listings.", "default": "both" }, "lookbackDays": { "title": "Lookback window (days)", "minimum": 1, "maximum": 1825, "type": "integer", "description": "How many days of completed HKEX IPOs to include when mode is 'recent' or 'both'. Default 30 days returns the most-recent month of pricing activity — typically 3-8 deals on Main Board plus 1-3 GEM listings in an active month. HKEX prices roughly 60-100 IPOs/year across Main Board + GEM; 90 days (~quarter) is the practical upper bound for institutional desk dashboards. Set higher (e.g. 365) for full-year vintage studies, post-IPO return cohort analysis or sponsor / underwriter league-table research.", "default": 30 }, "lookaheadDays": { "title": "Lookahead window (days)", "minimum": 1, "maximum": 365, "type": "integer", "description": "How many days of forward HKEX IPO calendar to include when mode is 'upcoming' or 'both'. Default 30 days returns the active book-build pipeline (deals with prospectuses live on the HKEX listing-committee hearing schedule). 60-90 days extends to the medium-term pipeline (deals with PHIP / Post-Hearing Information Pack filed but listing date not yet fixed). 180+ days surfaces the soft pipeline (rumored / sponsor-mandated but not yet PHIP-filed). HKEX has been the world's #1 IPO venue by proceeds in 5 of the last 15 years.", "default": 30 }, "listingBoard": { "title": "Listing board", "enum": [ "all", "Main Board", "GEM" ], "type": "string", "description": "Filter by HKEX board. 'Main Board' = senior board with quantitative entry tests (HK$50M profit test, HK$500M market-cap-revenue test, or HK$4bn market-cap-revenue-cashflow test); home to all the China large-cap A+H secondaries, BABA-class weighted-voting-rights listings (Chapter 8A), and Chapter 18A pre-revenue biotech listings. 'GEM' = growth-board (Growth Enterprise Market) — relaunched 2024 with revised rules; targets SMEs. 'all' returns both boards.", "default": "all" }, "sector": { "title": "GICS-style sector filter", "enum": [ "all", "Technology", "Healthcare", "Financials", "Consumer Discretionary", "Consumer Staples", "Industrials", "Energy", "Real Estate", "Materials", "Communication Services", "Utilities" ], "type": "string", "description": "Filter by sector classification. HKEX IPO sector mix has shifted dramatically since 2018: pre-2018 it was Financials (Chinese bank A+H, insurance), 2018-2021 was Technology (BABA, Meituan, JD.com secondaries, NetEase secondary, Bilibili), 2022-2024 was Healthcare (Chapter 18A pre-revenue biotech wave — InnoCare, Cansino, Innovent), 2024-2026 is Consumer Discretionary (HK consumer brand re-listings — Mixue Bingcheng, Chabaidao, Bawang Chaji, Laopu Gold) and a new Specialist Technology Companies (Chapter 18C) AI/semiconductor wave (Black Sesame, WeRide aspirations). 'all' = no filter.", "default": "all" }, "minProceedsHkdMillion": { "title": "Minimum gross proceeds (HKD millions)", "minimum": 0, "maximum": 100000, "type": "number", "description": "Lower bound on gross IPO proceeds in HKD millions. Use to filter out micro-cap GEM offerings. Typical thresholds: '50' = small Main Board, '500' = sizeable Main Board, '1000' = institutional-grade (HK$1bn+), '5000' = mega-deal (Midea Group HK$31bn, Mixue Bingcheng HK$3.4bn, S.F. Holding HK$5.7bn, Horizon Robotics HK$5.4bn class). Leave 0 for no lower bound. 1 HKD ≈ 0.128 USD.", "default": 0 }, "limit": { "title": "Max IPO records returned", "minimum": 1, "maximum": 200, "type": "integer", "description": "Hard cap on total HKEX IPO records returned (1-200). Each IPO is one dataset row. Premium pricing applies per row — HKEX IPO data is institutional intel (Bloomberg HK IPO / Refinitiv / Renaissance Capital equivalents cost USD 2,000+/seat/month). HKEX prices ~30-100 IPOs/year so most useful runs are limit=20-100. Records are sorted Upcoming-first by listing date ascending, then completed-IPOs by ipo_date descending.", "default": 25 } } }, "runsResponseSchema": { "type": "object", "properties": { "data": { "type": "object", "properties": { "id": { "type": "string" }, "actId": { "type": "string" }, "userId": { "type": "string" }, "startedAt": { "type": "string", "format": "date-time", "example": "2025-01-08T00:00:00.000Z" }, "finishedAt": { "type": "string", "format": "date-time", "example": "2025-01-08T00:00:00.000Z" }, "status": { "type": "string", "example": "READY" }, "meta": { "type": "object", "properties": { "origin": { "type": "string", "example": "API" }, "userAgent": { "type": "string" } } }, "stats": { "type": "object", "properties": { "inputBodyLen": { "type": "integer", "example": 2000 }, "rebootCount": { "type": "integer", "example": 0 }, "restartCount": { "type": "integer", "example": 0 }, "resurrectCount": { "type": "integer", "example": 0 }, "computeUnits": { "type": "integer", "example": 0 } } }, "options": { "type": "object", "properties": { "build": { "type": "string", "example": "latest" }, "timeoutSecs": { "type": "integer", "example": 300 }, "memoryMbytes": { "type": "integer", "example": 1024 }, "diskMbytes": { "type": "integer", "example": 2048 } } }, "buildId": { "type": "string" }, "defaultKeyValueStoreId": { "type": "string" }, "defaultDatasetId": { "type": "string" }, "defaultRequestQueueId": { "type": "string" }, "buildNumber": { "type": "string", "example": "1.0.0" }, "containerUrl": { "type": "string" }, "usage": { "type": "object", "properties": { "ACTOR_COMPUTE_UNITS": { "type": "integer", "example": 0 }, "DATASET_READS": { "type": "integer", "example": 0 }, "DATASET_WRITES": { "type": "integer", "example": 0 }, "KEY_VALUE_STORE_READS": { "type": "integer", "example": 0 }, "KEY_VALUE_STORE_WRITES": { "type": "integer", "example": 1 }, "KEY_VALUE_STORE_LISTS": { "type": "integer", "example": 0 }, "REQUEST_QUEUE_READS": { "type": "integer", "example": 0 }, "REQUEST_QUEUE_WRITES": { "type": "integer", "example": 0 }, "DATA_TRANSFER_INTERNAL_GBYTES": { "type": "integer", "example": 0 }, "DATA_TRANSFER_EXTERNAL_GBYTES": { "type": "integer", "example": 0 }, "PROXY_RESIDENTIAL_TRANSFER_GBYTES": { "type": "integer", "example": 0 }, "PROXY_SERPS": { "type": "integer", "example": 0 } } }, "usageTotalUsd": { "type": "number", "example": 0.00005 }, "usageUsd": { "type": "object", "properties": { "ACTOR_COMPUTE_UNITS": { "type": "integer", "example": 0 }, "DATASET_READS": { "type": "integer", "example": 0 }, "DATASET_WRITES": { "type": "integer", "example": 0 }, "KEY_VALUE_STORE_READS": { "type": "integer", "example": 0 }, "KEY_VALUE_STORE_WRITES": { "type": "number", "example": 0.00005 }, "KEY_VALUE_STORE_LISTS": { "type": "integer", "example": 0 }, "REQUEST_QUEUE_READS": { "type": "integer", "example": 0 }, "REQUEST_QUEUE_WRITES": { "type": "integer", "example": 0 }, "DATA_TRANSFER_INTERNAL_GBYTES": { "type": "integer", "example": 0 }, "DATA_TRANSFER_EXTERNAL_GBYTES": { "type": "integer", "example": 0 }, "PROXY_RESIDENTIAL_TRANSFER_GBYTES": { "type": "integer", "example": 0 }, "PROXY_SERPS": { "type": "integer", "example": 0 } } } } } } } } } } ```